Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial Hypertension

ClinicalTrials.gov ID: NCT03657095

Public ClinicalTrials.gov record NCT03657095. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 8:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Extension of BPS-314d-MR-PAH-302 in Pulmonary Arterial Hypertension Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center, open-label study for eligible participants who were actively participating in the BPS-314d-MR-PAH-302 double-blind study (NCT01908699) at the time the study was concluded. This open-label extension (OLE) study will evaluate the safety, tolerability, and efficacy of long-term treatment with esuberaprost sodium tablets (Beraprost Sodium 314d Modified Release tablets).

Study identification

NCT ID
NCT03657095
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lung Biotechnology PBC
Industry
Enrollment
112 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 10, 2018 (Actual)
Primary completion
Jul 20, 2019 (Actual)
Completion
Jul 20, 2019 (Actual)
Last update posted
Sep 7, 2020

2018 – 2019

United States locations

U.S. sites
43
U.S. states
22
U.S. cities
40
Facility City State ZIP Site status
The University of Alabama at Birmingham Birmingham Alabama 35294 —
Cedars-Sinai Medical Center Beverly Hills California 90211 —
University of California San Diego Medical Center La Jolla California 92093 —
University of California Los Angeles UCLA Los Angeles California 90024 —
West Los Angeles VA Healthcare Center Los Angeles California 90073 —
Santa Barbara Pulmonary Associates Santa Barbara California 93102 —
Stanford Hospital and Clinics Stanford California 94305 —
Harbor-UCLA Medical Center Torrance California 90502 —
Allianz Research Institute Westminster California 92683 —
University of Colorado Health Sciences Center Aurora Colorado 80045 —
Aurora Denver Cardiology Associates Denver Colorado 80128 —
South Denver Cardiology Associates Littleton Colorado 80120 —
Bay Area Cardiology Research Brandon Florida 33511 —
University of Florida Clinical Research Center Gainesville Florida 32610 —
Florida Hospital Orlando Florida 32803 —
South Miami Heart Specialists South Miami Florida 33143 —
Cleveland Clinic Florida Weston Florida 33331 —
Emory University Atlanta Georgia 30322 —
Pulmonary & Critical Care of Atlanta Atlanta Georgia 30342 —
Georgia Clinical Research Austell Georgia 30106 —
Indiana University Health North Hospital Indianapolis Indiana 46202 —
University of Iowa Hospitals and Clinics Iowa City Iowa 54224 —
University of Louisville Research Foundation Louisville Kentucky 40202 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Johns Hopkins University Baltimore Maryland 21205 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Beaumont Health Troy Michigan 48085 —
Albany Medical Center Albany New York 12208 —
The Mount Sinai Hospital New York New York 10029 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 —
Duke University Medical Center Durham North Carolina 27710 —
The Ohio State University Wexner Medical Center Columbus Ohio 43221 —
The University of Toledo Toledo Ohio 43614 —
Oregon Health and Science University Portland Oregon 97239 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
Rhode Island Hospital Providence Rhode Island 02903 —
Anderson Pharmaceutical Research, LLC Anderson South Carolina 29621 —
UT Southwestern Medical Center Dallas Texas 75390 —
Scott & White Memorial Hospital Temple Texas 76508 —
Sentara Cardiovascular Research Institute Norfolk Virginia 23507 —
University of Washington Medical Center Seattle Washington 98195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03657095, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 7, 2020 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03657095 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →